Outpatient Pharmacy Services

Portsmouth Hospitals University NHS Trust, a public-sector buyer, is inviting bids for pharmacy services in United Kingdom. Bids close on 31 Dec 2026 (in 43 days). The stated value is £30.7m.

Read the official notice Add to calendar

At a glance

Buyer
Portsmouth Hospitals University NHS Trust (Public sector)
Notice
Pre-qualification
Category
Pharmacy services
Where
South East · United Kingdom
Estimated value
£30.7m
Published
10 Nov 2026
Closes
31 Dec 2026 · in 43 days
How to bid
As the official notice sets out

The buyer's description

Delivery of the outpatient pharmacy services within the Queen Alexandra hospital at Portsmouth Hospitals University NHS Trust.

From the official notice

Procurement identifier (OCID): ocds-h6vhtk-07b8fd

Portsmouth Hospitals University NHS Trust

Queen Alexandra Hospital Southwick Hill Road

Access to the procurement documents is restricted. Further information can be obtained at

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted to the above-mentioned address

Delivery of the outpatient pharmacy services within the Queen Alexandra hospital at Portsmouth Hospitals University NHS Trust.

Outpatient Pharmacy Services - Procurement approach.

The current contract is due to expire on the 31st of January 2027

The contract was novated to Rowlands Pharmacy LTD for 2 years, for a total Value of circa £28,000,000

The Contracting Authority is to undertake a Direct Award Process C under the PSR regulations and award a new contract to the incumbent supplier until a competitive process can be awarded.

The key criteria to award a contract via award Direct Award Process has been analysed by the Pharmacy department. Key observations include the following.

The provider is already established in the Trust and has a good working relationship with Pharmacy Care Group. To date there have been no serious incidents or harm reported related to the service. To continue with this provider reduces the risk of service disruption and patient harm that may otherwise arise from a rapidly expedited change in provider.

The provider continues to monitor and respond to any safety learning events or complaints in collaboration with the Medication Safety Team and the wider Pharmacy Care Group to ensure patient safety. They also support patients through medication counselling and advice

Price is not the only award criterion and all criteria are stated only in the procurement documents

This contract is to be awarded and subject to the Health Care Services (Provider Selection Regime) Regulations 2023 via direct award process C.

Prior market engagement was undertaken in April 2026 to determine the risk and issues of undertaken a competitive process where the service model and specification were consulted. The specification for a long term contract award is taking place and a further market engagement notice will be published in the new year. This contract is therefore a short term solution,

For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

The procurement is covered by the Government Procurement Agreement: Yes

Independent patient choice and procurement panel

Independent patient choice and procurement panel

Similar open tenders

All sections

Edition